Business

Microbot Medical Expands its Physician Support with the Addition of Leading Italian Interventional Radiologist Irene Bargellini, M.D., to its Scientific Advisory Board

Believes that the reduction in radiation exposure the LIBERTY® system could empower more women to pursue careers in Interventional Radiology HINGHAM, Mass.,

articleMicrobot Medical Inc.July 11, 20233/company/microbot-medical-inc/news/microbot-medical-expands-its-physician-support-with-the-addition-of-leading-italian-interventional-radiologist-irene-bargellini-md-to-its-scientific-advisory-board
Microbot Medical Expands its Physician Support with the Addition of Leading Italian Interventional Radiologist Irene Bargellini, M.D., to its Scientific Advisory Board

About this update from Microbot Medical Inc.

[{"type":"text","content":"Believes that the reduction in radiation exposure the LIBERTY® system could empower more women to pursue careers in Interventional Radiology\nHINGHAM, Mass., July 11, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular robotic surgical system, today announced that Irene Bargellini, M.D., an interventional radiologist and Chair of the Diagnostic and Interventional Radiology Department at Candiolo Cancer Institute in Turin, Italy, has joined the Company’s Scientific Advisory Board (SAB). Dr. Bargellini is the latest expansion of Microbot’s global presence with highly esteemed medical experts in large addressable markets. Dr. Bargellini’s primary clinical and scientific focus is on oncologic imaging and interventional oncology, with reference to liver imaging and liver tumors’ loco-regional and systemic therapies. “It is encouraging that leading interventional radiologists continue to join Microbot as it embarks on the steps towards the commercialization of the system,” commented Eyal Morag, MD, Chief Medical Officer. “In addition to leveraging Dr. Bargellini’s expertise to achieve this goal, we also recognize that Italy represents an important and potentially large addressable market for the LIBERTY Robotic Surgical System. Dr. Bargellini is a potential future user, who we believe could support our entry into the Italian market upon regulatory clearance.” “I believe it’s important to support technology that can advance medicine and improve patient outcomes, and having experienced the system first-hand, I am eager to lend my capabilities and contribute to the system’s success,” commented Dr. Bargellini. “Additionally, I believe the potential of the LIBERTY Robotic Surgical System to reduce the level of radiation exposure makes it possible for more women to pursue a career as interventional radiologists, while not potentially endangering their health and/or ability to have children.” Dr. Bargellini is Member of the Executive Committee of Italian Society of Radiology (SIRM), fellow of the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) and the Cardiovascular and Interventional Radiology Society in Europe (CIRSE), and member of the European Society of Radiology (ESR), European Society for the Study of the Liver (EAS...

More updates from Microbot Medical Inc.